Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau340 enrolled

Overview

Observational study aimed to test the ability of Neutrophil Gelatinase-associated Lipocalin (NGAL) concentration in blood and urine to predict and diagnose early acute renal failure (ARF) in patients after cardiac surgery with/without Cardiopulmonary bypass (CPB).

Study Type

OBSERVATIONAL

Enrollment

340

Conditions

Cardiac Surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men or women over 18 years proposed for cardiac surgery with / without CPB. * Accepting to participate in the study, with informed consent signed by the patient, guardian or family member. Exclusion Criteria: * Patients \< 18 years. * Patients do not agree to participate in the study.

Locations (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, Barcelona, Spain

RECRUITING

Central Contacts

Mercedes Garcia, MD

CONTACT

+34 93 553 75 41 mgarciaa@santpau.cat

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.